Skip to main content
. 2015 Oct;12(10):1506–1513. doi: 10.1513/AnnalsATS.201501-058OC

Figure 6.

Figure 6.

Decreased plasma miR-17 and -19b expression in the first week of life in infants who subsequently developed bronchopulmonary dysplasia (BPD). (A and B) Expression (mean ± SD) of miR-17 and - 19b in control (n = 10) and BPD (n = 11) plasma samples was determined using lipoplex nanoparticles containing molecular beacons. (C and D) Receiver operating characteristic curves were estimated to determine the extent to which miR concentrations predicted BPD at 36 weeks’ postmenstrual age.